Annovis Bio, which raised $600 million in value from a $10 million IPO in December 2020, is one of David's IPOs. David worked at ImClone Systems as the Vice President of Finance and Investment Strategy, reporting to the CEO and the Board of Directors, and at ThinkEquity as the Managing Director of Healthcare Banking.